ESC 365 - All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - PRO.

ESC Premium Access

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - PRO.

Session: Controversies in antithrombotic treatment for primary and secondary prevention

Topic: Pharmacology and Pharmacotherapy

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

37 presentations

0 follower

5 more presentations in this session

Aspirin is out for primary prevention of cardiovascular disease - PRO.

Speaker: Professor J. Armitage (Oxford, GB)

Aspirin is out for primary prevention of cardiovascular disease - CON.

Speaker: Professor C. Patrono (Rome, IT)

Aspirin is out for primary prevention of cardiovascular disease - Discussion.

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - CON.

Speaker: Doctor T. Cuisset (Marseille, FR)

All patients with atherosclerotic disease should receive long-term intensified antithrombotic treatment beyond aspirin for secondary prevention - Discussion.

Access the full session

Controversies in antithrombotic treatment for primary and secondary prevention

Speakers: Doctor J. Eikelboom, Professor J. Armitage, Professor C. Patrono, Doctor T. Cuisset

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources